Our Metformin HCl 50 mg/ml Transdermal Gel is a specialized semisolid formulation designed for targeted treatment through the skin. This innovative gel is dispensed via a pump mechanism, ensuring ease of use and precise dosing. The gel's consistency allows for smooth application and consistent delivery of metformin hydrochloride to the systemic circulation. This formulation is primarily used in the management of type 2 diabetes mellitus, aiming to improve glycemic control by reducing hepatic glucose production and enhancing insulin sensitivity. Additionally, it may be utilized in addressing polycystic ovary syndrome (PCOS), where it helps in restoring normal menstrual cycles and reducing insulin resistance.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Metformin HCl 50 mg/ml Transdermal Gel is a specialized medication formulated for transdermal delivery, providing an alternative route of administration for patients who may have difficulties with oral dosage forms. This semisolid formulation is designed to be dispensed through a pump mechanism, which ensures ease of use and precise dosing. The gel-like consistency allows for targeted application on the skin, where the active ingredient, Metformin HCl, can be absorbed systematically.
Metformin, a biguanide class of medication, is primarily used in the management of type 2 diabetes mellitus. It works by decreasing hepatic glucose production, reducing intestinal absorption of glucose, and improving insulin sensitivity by increasing peripheral glucose uptake and utilization. While traditionally administered orally, the transdermal route offers potential benefits such as bypassing gastrointestinal side effects, avoiding first-pass metabolism, and providing a steady release of medication over time.
The transdermal gel formulation may be particularly beneficial for patients with gastrointestinal intolerance to oral metformin or those with compliance issues. The concentration of Metformin HCl in the gel has been optimized to achieve therapeutic levels, assuming proper adherence to the prescribed regimen.
Patients and prescribers should be aware that the efficacy and safety of transdermal Metformin HCl gel for the treatment of type 2 diabetes have to be evaluated on an individual basis. Monitoring of blood glucose levels and potential adjustments in dosing may be necessary to achieve optimal glycemic control. Additionally, patients should be instructed on the proper application site and technique to maximize drug absorption and minimize potential skin irritation.
As compounding pharmacists at Bayview Pharmacy, we are committed to providing high-quality, customized medications to meet the unique needs of our patients. We encourage patients and prescribers with questions or concerns about Metformin HCl 50 mg/ml Transdermal Gel to reach out to us. Our team is ready to provide the necessary support, guidance, and information to ensure the safe and appropriate use of this formulation.
Metformin HCl is primarily known for its use in the management of type 2 diabetes mellitus, where it works by decreasing hepatic glucose production, decreasing intestinal absorption of glucose, and improving insulin sensitivity by increasing peripheral glucose uptake and utilization. While the majority of data on metformin pertains to its oral administration, the transdermal route offers an alternative for patients who may have gastrointestinal side effects or contraindications to oral use. However, it is important to consider that the pharmacokinetics and potential interactions of transdermal metformin may differ from the oral form.
When using Metformin HCl 50 mg/ml Transdermal Gel, it is crucial to be aware of potential drug interactions that could affect the efficacy of the treatment or cause adverse effects. Metformin is known to interact with a number of medications. For instance, concomitant use with insulin or insulin secretagogues (such as sulfonylureas) can increase the risk of hypoglycemia. Patients should be closely monitored for signs of low blood sugar, and the dose of insulin or sulfonylureas may need to be adjusted accordingly.
Additionally, certain drugs may affect renal function, which is particularly important for metformin since it is excreted by the kidneys. Medications such as NSAIDs, ACE inhibitors, and diuretics can affect kidney function and may increase the risk of lactic acidosis, a rare but serious complication associated with metformin. Patients should be advised to stay well-hydrated and to report any signs of lactic acidosis, such as muscle pain or weakness, respiratory distress, and abdominal discomfort.
Alcohol can also interact with metformin, increasing the risk of lactic acidosis. Patients should be counseled to limit alcohol intake while using this medication. Moreover, certain contrast agents used in diagnostic procedures can affect kidney function and should be used with caution in patients receiving metformin. It may be necessary to temporarily discontinue the transdermal gel prior to the administration of iodinated contrast media.
Other medications that can affect blood glucose levels, such as corticosteroids, thyroid products, oral contraceptives, and antipsychotics, may require dose adjustments of metformin or close monitoring of blood glucose levels. Additionally, the absorption or efficacy of metformin may be influenced by drugs that alter gastric pH, such as proton pump inhibitors and H2 receptor antagonists, although this is more relevant to oral administration and may not be as significant for transdermal application.
It is also important to note that the transdermal route bypasses the gastrointestinal system, which may reduce the likelihood of gastrointestinal interactions; however, the systemic effects of metformin remain. Patients should be instructed to apply the gel as directed and to the specified skin area to ensure consistent absorption. They should also be aware that the skin site should be clean, intact, and free of other topical products to prevent altered absorption or local skin reactions.
Given the complexity of drug interactions with metformin, prescribers should review the patient's complete medication profile for potential interactions before initiating treatment with Metformin HCl 50 mg/ml Transdermal Gel. Pharmacists can provide valuable guidance on managing these interactions and optimizing therapy. If you have any questions or require further information regarding this formulation and its interactions, please reach out to us at Bayview Pharmacy.
Metformin HCl 50 mg/ml Transdermal Gel is a novel formulation designed to deliver the active pharmaceutical ingredient, Metformin HCl, through the skin directly into the systemic circulation. This semisolid formulation is dispensed through a pump mechanism, which ensures that a precise dose of the medication is administered with each pump. The gel is designed to be applied topically, which can be particularly beneficial for patients who may have difficulties with oral administration or those who experience gastrointestinal side effects commonly associated with oral metformin.
The transdermal delivery system works by incorporating Metformin HCl into a gel base that facilitates the drug's penetration through the stratum corneum, the outermost layer of the skin. Once through the skin barrier, the drug enters the dermal layer where it can be absorbed into the bloodstream. The gel base is formulated with penetration enhancers that increase the permeability of the skin to Metformin HCl. The transdermal route also bypasses the first-pass metabolism in the liver, which can result in a more efficient delivery of the active ingredient to the body's tissues.
Metformin is primarily used in the treatment of type 2 diabetes mellitus, where it works by decreasing hepatic glucose production, decreasing the intestinal absorption of glucose, and improving insulin sensitivity by increasing peripheral glucose uptake and utilization. By managing blood glucose levels, metformin helps to prevent the long-term complications of diabetes, such as neuropathy, retinopathy, and cardiovascular disease. The transdermal formulation may offer an alternative for patients who are not well-controlled on oral metformin or for those who are unable to tolerate the oral formulation due to gastrointestinal side effects.
It is important for both patients and prescribers to understand that while the transdermal route offers advantages, it also requires careful consideration of the skin's condition and the site of application. The skin should be intact, without cuts or irritations, to ensure proper drug delivery and to prevent skin irritation. Additionally, the site of application should be rotated to prevent skin irritation. Patients should be instructed on how to use the pump mechanism and apply the gel correctly to ensure consistent dosing.
If you have any questions about the Metformin HCl 50 mg/ml Transdermal Gel, or if you would like more information on how this formulation can benefit specific patient populations, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is dedicated to providing in-depth knowledge and support to ensure the safe and appropriate use of our formulations.
Metformin HCl 50 mg/ml Transdermal Gel is formulated for patients who require an alternative to oral metformin therapy. This gel is absorbed through the skin and may be used in the management of type 2 diabetes to improve glycemic control.
Clean and dry the area of skin where the gel will be applied. Dispense the prescribed amount using the pump mechanism and apply it to the skin with a gentle rubbing motion until the gel is absorbed. Use the medication as directed by your healthcare provider.
No, you should apply Metformin Gel to areas recommended by your healthcare provider, often areas with thin skin such as the inner wrists or forearms, to ensure proper absorption of the medication.
The frequency of application will depend on your individual treatment plan prescribed by your healthcare provider. It is important to follow their instructions carefully and not to alter the dosage without consulting them.
Possible side effects can include skin irritation at the application site, such as redness, itching, or rash. Less commonly, similar systemic side effects to oral metformin may occur, including gastrointestinal complaints. If you experience any concerning symptoms, contact your healthcare provider immediately.
The transdermal gel is designed to deliver metformin into the bloodstream through the skin. While it serves the same purpose as the oral form, effectiveness may vary between individuals. Your healthcare provider will monitor your response and adjust your treatment accordingly.
If you miss a dose, apply it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not double doses to make up for a missed one.
It is recommended to wait at least 30 minutes to one hour after application before showering or swimming to allow the medication to be properly absorbed through the skin.
Store the gel at room temperature, away from direct sunlight and heat. Do not freeze. Keep the container tightly closed and out of reach of children and pets.
Not everyone with type 2 diabetes will be a candidate for transdermal therapy. This form of treatment can be particularly beneficial for patients who have difficulty swallowing pills or who experience gastrointestinal side effects from oral metformin. Always consult with your healthcare provider to determine if this formulation is appropriate for your specific medical condition.
Remember, this FAQ section is a general guideline and does not replace professional medical advice. Always consult with your healthcare provider for personalized instructions and information regarding your health and the medications you are using.This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)